European Archives - Page 668 of 1176 - European Medical Journal

EMJ Gastroenterology 9.1 2020 Feature Image

EMJ Gastroenterology 9.1 2020

EMJ Gastroenterology 9.1 is essential reading for all those interested in novel and emerging therapies for inflammatory bowel disease, stem cell therapies for inflammation-associated sigmoid colon diseases, and other key developments in the field. This journal also presents summaries of abstracts presented at UEG Week Virtual 2020, as well as interviews with UEG Council representatives.

EMJ Gastroenterology 9.1 2020 Feature Image

Review of the United European Gastroenterology (UEG) Week Virtual 2020

WILLKOMMEN IN WIEN” were the words that delegates expected to hear when arriving in Vienna, Austria, to participate in the United European…

Impact of COVID-19 on Patients with Inflammatory Bowel Disease: Update from an International Registry

Patients with inflammatory bowel disease (IBD) are frequently on immunosuppressive treatments that increase the risks of infection…

Dynamic Management of Crohn’s Disease: Reaching a New Dimension in Patient Care

Prof Peyrin-Biroulet started the symposium by describing how the focus of inflammatory bowel disease (IBD) therapy is moving toward disease…

EMJ Gastroenterology 9.1 2020 Feature Image

Use of a Machine Learning Algorithm to Predict Rebleeding and Mortality for Oesophageal Variceal Bleeding in Cirrhotic Patients

Oesophageal variceal bleeding (OVB) is one of the most common complications of cirrhosis. Mortality rates range from 15% to 20% in the first episode…

EMJ Gastroenterology 9.1 2020 Feature Image

Impact of Prenatal Stress on Visceral Sensitivity and Intestinal Homeostasis in Adulthood

Irritable bowel syndrome (IBS) affects 10–15% of the world population…

Ulcerative Colitis: Today, Tomorrow, and the Future

Crohn’s disease (CD) and UC are chronic inflammatory bowel diseases (IBD) that lead to digestive disorders and inflammation in the digestive system…

EMJ Gastroenterology 9.1 2020 Feature Image

Acute Infusion Reactions to Vedolizumab in Inflammatory Bowel Disease

Vedolizumab is a fully humanised, monoclonal IgG1 antibody, directed toward α4β7-integrin…

EMJ Gastroenterology 9.1 2020 Feature Image

The Gene Expression Signature Modulated by Dupilumab is Correlated with Histological Severity and Endoscopic Features of Mucosal Inflammation and Remodelling in Eosinophilic Oesophagitis

EoE is a chronic inflammatory disease triggered by an abnormal Type 2 inflammatory response to allergens, and is characterised by eosinophilic…

EMJ Gastroenterology 9.1 2020 Feature Image

The Incremental Benefit of Dye Chromoendoscopy Compared to High-Definition White Light and Virtual Chromoendoscopy for Lesion Assessment and Prediction of Submucosal Invasion

The identification of a demarcated area (DA), where a regular microvascular or pit pattern appears disordered, is a fundamental principle of optical evaluation and can predict the presence of submucosal invasive cancer (SMIC) in large (≥20 mm) nonpedunculated colorectal polyps (LNPCP)…